The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy
about
Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-AnalysisThe potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivoNanoparticle-based targeted therapeutics in head-and-neck cancerRecent developments in targeting carbonic anhydrase IX for cancer therapeuticsA pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinomaVariation and significance of secretory immunoglobulin A, interleukin 6 and dendritic cells in oral cancer.Clinical biomarkers for hypoxia targetingDifferential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.Anticancer mechanism of apigenin and the implications of GLUT-1 expression in head and neck cancers.Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research programHypoxia in head and neck cancer.Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis.Significance of pH regulation and carbonic anhydrases in tumour progression and implications for diagnostic and therapeutic approaches.Biogenesis of intronic miRNAs located in clusters by independent transcription and alternative splicingNecrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.Mononuclear phagocytes in head and neck squamous cell carcinoma.Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells.Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors.The role of carbonic anhydrase IX in hypoxia control in OSCC.Carbogen gas and radiotherapy outcomes in prostate cancer.Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers.Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers.Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.Hypoxia as a Biomarker and for Personalized Radiation Oncology.Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro.Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency.Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1α and malignant potential in pancreatic neuroendocrine tumorsGlucose transporter-1 as a new therapeutic target in laryngeal carcinoma.Use of multiple biological markers in radiotherapy-treated head and neck cancer.Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers.Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation.Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy.
P2860
Q26749393-A28DB59A-2DDE-4A16-98A3-C9AB8BF9DABDQ26827175-806B29A6-27BF-42A5-B83B-0FDD0EFB12B0Q26999699-5EAEF85A-3097-4969-A9A8-20ECF9CA2E48Q27013023-5563ED03-F462-46BE-A3DC-A0CD8FC14EFDQ30317585-94E52B2B-8DFD-436C-843E-6708BC36C889Q30528676-CE8811B0-6EF7-4B1F-89BA-90B456F4AE33Q33598073-943279AC-7F43-4CB6-9D31-5C0B9BA8A73EQ33714638-842FD162-1C40-49FA-AB9C-763AD94EA42BQ34218825-7DB5EFAB-6007-4D98-9C16-F0CB1413DD9AQ34366965-BB50BCF5-390D-4527-A16B-65C394893644Q36117881-6E005A59-FA61-468C-8053-11269CF678B3Q36541242-42FE37C8-DF7D-4B2A-AA66-2057576419CCQ36616576-D7B334EB-FB25-435C-96F0-ACF9B7D0D3BCQ36740205-CCC90DF6-7872-4F23-883A-B977C1F40DB0Q37145164-FB4DF23B-E553-4B2F-9CC7-CEB351124E28Q37400282-DF08BD10-F199-4AD2-89A2-8604FAA051FBQ37453556-4CA2AC47-4F82-48F9-AE8D-F8E9A1BDDBE9Q37646333-018BCB95-A619-4B5B-91D5-D41A8E1CA8C3Q37690276-0429E776-F2D3-4F20-AEAA-6DE55B6574A0Q37696181-C132C0C5-1345-41F6-AB06-43DD59054D91Q37706691-A3FB0335-81EC-4DF1-B33E-5F830B85A040Q37710994-B187A3A1-ACF2-43E2-90CA-021D0ADA1C0AQ37993617-5D87273B-496C-463C-9D27-4DF25E6FD23EQ38078362-42B7A5A8-30AD-4D9A-9BB5-1C8026156A3FQ38132855-C2C4762D-29C3-4940-9838-64CF198248B2Q38154554-2618AE3D-ED29-43EA-9FA7-876048662590Q38209889-773D518C-377A-409B-984E-E9F2A5A4FAE7Q38224477-E6120807-E7E5-4B82-9469-3865348D56D3Q38618620-2B27537C-456F-480B-A589-D89178F41BFFQ38869433-DFD5B433-F0D1-4282-8302-C46B8AE779B5Q39326693-E524E52F-5877-4303-B935-1006FBC9DECEQ39561817-15553F05-140C-45A9-9D9B-ED3C1B299384Q42370634-641894E8-E74A-411F-9AA7-D814718012A9Q42758534-B9F9DAFB-A8E4-45F1-9A23-79EE0B3974E7Q43101270-83388C28-8EA5-44DF-ACBE-30BACE4813C8Q43543147-74B84604-7A6E-43D8-ABD2-058224E45033Q44608391-FB5D257B-B05F-48FF-8B3A-F9A4B27FCE64Q46523178-BE2F775E-5DB8-4C83-A9C9-B2F47F6E81FBQ51791167-B49D0B36-F006-460D-90AB-16464BB562F6Q53213701-800EE1EB-0970-4E72-8D3A-4387E98A53BA
P2860
The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@ast
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@en
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@nl
type
label
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@ast
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@en
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@nl
prefLabel
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@ast
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@en
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
The prognostic value of the hy ...... radiotherapy +/- chemotherapy
@en
P2093
Harlinde De Schutter
Laurence Goethals
Robert Hermans
Sandra Nuyts
Willy Landuyt
P2860
P2888
P3181
P356
10.1186/1471-2407-5-42
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1034835344